Nano1Health SL

Logo Nano1Health

Contact information

Nano1Health SL
Olga Francino Martí, CEO
Edificio Eureka (PRUAB), Campus UAB
Bellaterra
08193 Barcelona
+34 663882486
Areas of activities
  • A. Health Biotechnology
    • Areas of activity
      • Biomarkers
      • In vitro diagnostics
    • Therapeutic areas
      • Dermatology
      • Infectious diseases
      • Oncology
  • B. Agrifood Biotechnology
    • Agriculture / veterinary / environmental
      • Animal health / Veterinary
  • C. Industrial Biotechnology
    • Microorganism
  • D. Services
    • R&D services
      • Bioinformatics
      • Biotechnolgy kits
      • Genomics
      • CRO / CMO / SMO
    • Professional services
      • Consultancy

Nano1Health (N1H) joins the expertise of skilled and highly valued veterinarians, geneticists, and bioinformaticians to rapidly characterize microbiomes, identify pathogens, drug resistance genes, and other biomarkers of interest in both infectious and genetic diseases. We innovate on how to manage, process, and interpret your studies and genomic data.

Products and services

At Nano1Health, we generate the most relevant applications of disruptive sequencing technology and state-of-the-art data analyses to develop and transfer easy-to-use solutions (i.e., diagnostic tools, training, reports, products …) to our community for decentralized genomics analyses.

As a CRO, we can council our customers with their projects. From the data generation process (sequencing) to developing or adapting specific bioinformatic strategies tailored to their needs. Additionally, we can help with your sequencing and long-term data storage and analysis.
 

Areas of interest for future collaborations

Infectious diseases, diagnostics, microbiome studies, drug resistance, oncogenetics, animal health, human health, pathogen discovery.